Access to Medicines

Activity List

• 
  Beating 10 Diseases, Improving 1 Billion Lives Participation in 5-Year Anniversary of London Declaration Event

  April 20, 2017

• 
  Eisai's Involvement in New Partnership to Provide Diagnostic Kits for Lymphatic Filariasis

  February 17, 2016

• 
  Eisai Begins Free Supply of DEC Tablets to Eliminate Lymphatic Filariasis

  November 18, 2013

• January 20, 2017

  Eisai Participates in Access Accelerated, a Global Partnership to Advance Access to Non-Communicable Diseases Prevention, Treatment and Care in Low and Lower-Middle Income Countries

• June 3, 2016

  Creating Leaflet for DEC Tablets in Local Languages for Endemic Countries

• March 18, 2016

  Reaching the 2 Billion: The Japanese Pharmaceutical Industry's Contributions to Access to Medicine

• February 10, 2016

  DEC Project Managers' Efforts to Support Lymphatic Filariasis Elimination Activities in Indonesia

• February 20, 2015

  Eliminating Lymphatic Filariasis and Other Neglected Tropical Diseases (NTDs) by 2020

• January 27, 2015

  Evaluating Eisai's Efforts to Improve Access to Medicines #2 -The ATM Index Ranking 2014-

• March 27, 2014

  Eisai's Challenge of Greater Access to Medicines: Tackling Lymphatic Filariasis (video presentation)

• February 17, 2014

  Evaluating Eisai's Efforts to Improve Access to Medicines -The ATM Index Ranking-

• September 2, 2013

  Neglected Tropical Diseases: From Promises to Progress Tackling Lymphatic Filariasis in Madagascar and Beyond (video presentation)

• November 7, 2012

  The First Shipment of DEC Tablets to WHO in Effort to Help Eliminate Lymphatic Filariasis

• August 20, 2012

  London Declaration-Eisai Increases its Commitment to Fight Neglected Tropical Diseases

• June 29, 2011

  Status of DEC Provision Program for WHO

Current Distribution Status of DEC Tablets for Endemic Countries

• In November 2010, Eisai agreed to provide 2.2 billion DEC (diethylcarbamazine) tablets free of charge through WHO to lymphatic filariasis endemic countries worldwide by 2020
• In August 2013, Eisai's DEC tablets obtained prequalification from WHO, the first Neglected Tropical Disease treatment to receive prequalification in the world
• In October 2013, DEC tablet provision commenced from our Vizag plant
• In April 2017, Eisai announced that it would continue to provide DEC tablets to endemic countries that need them beyond 2020, until complete elimination is achieved

■Countries where DEC tablets are scheduled to be supplied by 2020

● Countries where distribution has commenced